School of Medicine
Showing 71-80 of 863 Results
-
Landon Bradshaw
MD Student with Scholarly Concentration in Health Services & Policy Research / Health Equity and Social Justice, expected graduation Winter 2029
BioLandon Bradshaw is a medical student at Stanford University School of Medicine with interests in gastroenterology-related illnesses, health policy, and advancing health equity. His work focuses on how healthcare policy and system-level structures influence access to high-quality cancer care, particularly among historically underserved populations.
He conducts health services and outcomes research in the Stanford Surgery Policy Improvement Research & Education Center (Dawes Lab), where he examines the impact of Medicaid expansion on treatment utilization and survival outcomes in metastatic colorectal cancer. His broader research interests include evaluating policy mechanisms that drive adoption of innovative evidence-based therapies and designing system-level interventions that promote equitable care delivery.
At Stanford, Landon serves as President of the Stanford Medical Student Association, the elected governing body representing nearly 600 MD and PA students. In this role, he has led institutional initiatives focused on equity, community engagement, and resource stewardship, including securing funding for large-scale service-learning programming and implementing a formalized, equity-centered framework for student organization funding.
Landon is committed to a career at the intersection of academic medicine, policy, and leadership, with the goal of shaping healthcare systems that deliver high-value, equitable care at scale. -
Cort Breuer
Ph.D. Student in Immunology, admitted Autumn 2022
BioCort Breuer is currently an Immunology PhD student in the lab of Nathan Reticker-Flynn. Cort received his BS in Biological Engineering from Cornell University in 2022, where he studied lymphatic-cancer interactions and T cell mechanosensing in the lab of Esak Lee. Previously, he worked with James Moon at Massachusetts General Hospital to develop in vivo gene therapies for the immune system and with Michelle Krogsgaard at NYU Perlmutter Cancer Center to investigate structural biology of TCR signaling. Cort’s current work focuses on mechanisms of tumor-immune tolerance and decoding the antigen specificity of T cell receptors. Drawing on his engineering background, he designs new molecular tools to record how immune cells communicate and constructs therapeutics to target impaired immune responses.
